Loading…
| # | Company | Offered Item | Amount | Rank | Status |
|---|---|---|---|---|---|
| 1 | L1₹3.4 LQualified Make: BAXTER
Model: ADS201844 GT KARNAL ROAD INDUSTRIAL AREA NORTH DELHI DELHI 110033 | NORTH DELHI | DELHI | 110033 | Make: BAXTER
Model: ADS201844 | L1 | Qualified |
Tender Value
₹3.4 L
EMD Value
Exempted
Closing Date
2 Mar 2026, 3:00 pmClosed
Flowable Gelatin Hemostatic Matrix (V2) (Q2) (3 (3 ))
9012229
GEM/2026/B/7262333
Two Packet Bid
Flowable Gelatin Hemostatic Matrix (V2)
GeM Contract
New Delhi, Delhi
Total value wise evaluation
PRODUCT
Awarded to PHARMA SURGE IMPEX
₹3.4 L
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| BAXTER Flowable Gelatin Hemostatic Matrix 5 ml | BAXTER / ADS201844 | HSN not specified by seller | 20 pieces | 16,800 | 336,000 |
8 documents required · 8 mandatory
3 yrs
₹2 L
₹4 L
50%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| Flowable Gelatin Hemostatic Matrix (V2) (Q2) (3 (3 )) | - | 20 | - |
Exempted
Yes
6 Jun 2026
20 Feb 2026
2 Mar 2026
contract_GEMC-511687721544947.pdf
GEM_CONTRACT • 0.07 MB
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9012229.pdf
GEM_BID
IP_95102c37-7b36-4d92-a98c1771491037652_RAVI.VISHWAKARMA22.pdf
OTHER
ATC_cc17db95-2d59-4dbf-8afd1771491086859_RAVI.VISHWAKARMA22.pdf
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
IP_95102c37-7b36-4d92-a98c1771491037652_RAVI.VISHWAKARMA22.pdf
GEM_OTHER • 0.25 MB
ATC_cc17db95-2d59-4dbf-8afd1771491086859_RAVI.VISHWAKARMA22.pdf
GEM_OTHER • 0.21 MB
list-of-categories-where-trials-are-allowed_1712126171.pdf
GEM_OTHER • 0.52 MB
gtc.pdf
GEM_OTHER • 0.70 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .